4//SEC Filing
Riga Thomas J 4
Accession 0000899243-23-001066
CIK 0000831547other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 7:50 PM ET
Size
9.9 KB
Accession
0000899243-23-001066
Insider Transaction Report
Form 4
Riga Thomas J
Chief Operating Officer
Transactions
- Sale
Common Stock, $0.001 par value
2023-01-03$0.38/sh−23,929$9,141→ 1,189,411 total - Award
Common Stock, $0.001 par value
2023-01-03+888,000→ 2,077,411 total - Award
Stock Option (Right to Buy)
2023-01-03+3,112,000→ 3,112,000 totalExercise: $0.38Exp: 2033-01-03→ Common Stock (3,112,000 underlying)
Holdings
- 14,139(indirect: By 401(k))
Common Stock, $0.001 par value
Footnotes (3)
- [F1]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
- [F2]One third of the aggregate amount of restricted stock units shall vest on each of January 3, 2024, 2025 and 2026, respectively.
- [F3]One third of the aggregate amount of option shares shall vest on each of January 3, 2024, 2025 and 2026, respectively.
Documents
Issuer
SPECTRUM PHARMACEUTICALS INC
CIK 0000831547
Entity typeother
Related Parties
1- filerCIK 0001726378
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 7:50 PM ET
- Size
- 9.9 KB